Karyopharm Therapeutics – They continue to look for growth opportunities globally. | Comparably

Karyopharm Therapeutics – They continue to look for growth opportunities globally.

Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Angeforderte Firma
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Weiterlesen
Dieses Unternehmen nimmt Feedback von überprüften Mitarbeitern entgegen
MITARBEITER
TEILNEHMER
90
GESAMT
BEWERTUNGEN
2628

They continue to look for growth opportunities globally.

Was ist das Beste an Ihrem Vergütungspaket?

Our health, dental, and vision benefits our good!

Was macht Sie bei der Arbeit am glücklichsten?

Helping patients through collaboration and problem solving and my team.

Was sind einige der besten Dinge an Ihrem Team?

My team is the best! They are hard working, collaborative, fun, and always doing what they can to help patients.

Was ist am positivsten an Kultur und Umgang in Ihrem Unternehmen?

My team and my manager are very supportive. We always look to encourage each other and collaborate. My manager cares about me and my personal development.

×
Bewerten Sie Ihr Unternehmen